Cite
HARVARD Citation
Reig, M. et al. (n.d.). Postprogression survival of patients with advanced hepatocellular carcinoma: Rationale for second‐line trial design. Hepatology. 58 (6), pp. 2023-2031. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Reig, M. et al. (n.d.). Postprogression survival of patients with advanced hepatocellular carcinoma: Rationale for second‐line trial design. Hepatology. 58 (6), pp. 2023-2031. [Online].